How Extreme Exercise Affects Your Heart | Dr. Andy Galpin
In a Nutshell
Extreme endurance exercise can modestly elevate arrhythmia (AFib), coronary artery calcification, and myocardial fibrosis risk, mainly in men with decades of very high training volumes, yet these changes rarely increase mortality. VO2 max benefits continue to rise without an upper limit, and even extreme exercisers show lower overall death rates than less-fit peers. The practical takeaway: the cardiovascular upside of high fitness far outweighs the small, mostly theoretical downsides, so extreme training volumes are not clinically concerning for most people.
These notes were generated by AI and may contain inaccuracies.
If exercise is taken to an extreme, three primary maladaptations can plausibly occur. The first is arrhythmia risk (also referred to as AFib), where the electrical signaling or firing sequence becomes disrupted. The second is coronary artery calcification, where the coronary arteries supplying the heart become calcified, and rupture or bursting can lead to myocardial infarction. The third is myocardial fibrosis or scar tissue formation. These three issues represent the primary concerns when exercise-induced problems arise, distinct from genetic conditions such as hypertrophic cardiomyopathy (HCM).
The arrhythmia risk, particularly AFib, is documented and real. Research shows it is most prevalent among individuals combining both high intensity and high volume training over extended periods measured in years to decades. Short-term intensified training cycles lasting months do not carry the same concern. Data from a Swedish study of approximately 50,000 cross-country skiers found that those finishing in the top half of race groups (interpreted as those training more intensely) had a 1.3 times greater risk of AFib. Sub-analysis of individuals completing the race more than five times revealed an additional 1.3 risk factor. Expert consensus suggests the risk could reach up to five times higher for those engaging in high-intensity exercise over many years.
Athletes presenting with AFib from such databases typically have zero other known health risk factors that normally cause the condition. In the general population, AFib is almost always accompanied by hypertension, sleep apnea, valve disease, or cardiomyopathy. This absence of typical risk factors makes the condition harder to detect in athletes, earning it the description of a "silent killer." The functional adaptations from endurance training, including increased stroke volume and elevated vagal tone, are the same physiological changes that create AFib risk.
Current understanding suggests the problem may not stem purely from the combination of high-intensity and high-volume exercise, but rather from that exercise pattern interacting with an unidentified genetic predisposition in certain individuals. Screening tools may eventually be developed once more is understood about these genetic factors.
Despite a slight increase in AFib among endurance athletes, aerobic and endurance exercise produces massive reductions in overall mortality risk, heart disease risk, and virtually all other health outcomes measured. The vast majority of research on AFib in this context has been conducted in men, with insufficient data available for female athletes. Current evidence suggests the condition tends to occur less frequently in women, though the picture remains incomplete.
Ventricular arrhythmia (Vfib) represents an entirely different concern from AFib. Research examining over 200 elite athletes, including Olympic-level competitors, indicates that Vfib does not appear to be an exercise-induced adaptation. When ventricular arrhythmias are observed in athletes, they are likely not exercise-related and warrant attention.
Athletes frequently demonstrate elevated coronary artery calcification scores, though whether this represents actual pathology remains unclear. While calcification or plaque buildup is typically problematic in coronary arteries, the process in athletes may result from different mechanisms including inflammation, hemodynamic stress causing vascular tears, or vascular remodeling rather than atherosclerosis. The pathology remains unclear, and radiologists and cardiologists who regularly see athletic patients express confusion about the clinical significance.
Due to uncertainty about whether calcification represents normal adaptation in athletes, the default clinical approach involves treating elevated scores with statins or other medications rather than leaving them unaddressed. A Cooper Clinic study following over 26,000 people for multiple decades found that higher calcification scores correlated with increased heart attack risk and revascularization procedures, yet these same individuals showed lower all-cause mortality risk.
Research by Dr. Ben Levine indicates that physical activity levels exceeding 3,000 minutes per week correlate with increased calcification prevalence, but do not associate with increased all-cause or cardiovascular disease mortality even after a decade of follow-up, even among those with clinically significant coronary artery scores. This equates to approximately 30 miles per week of running at a 10-minute pace. Women athletes typically show no additional coronary artery problems compared to controls, suggesting this issue predominantly affects men.
Myocardial fibrosis (scarring) appears more associated with high-intensity exercise than lower-intensity activity. The scarring process can create mechanical stress, inflammation, ischemia, oxidative injury, and reduced chamber compliance. Fibrosis has been observed in the atria, right ventricle, septum, and other cardiac regions. Among the three maladaptations discussed, fibrosis has the most unclear supporting data.
A study of veteran endurance athletes over age 50 with cardiac fibrosis found a 5x increased risk of non-benign ventricular arrhythmia. However, these individuals averaged 12 hours of exercise weekly for over 20 years while competing approximately 20 times annually. This represents extreme training volumes (equivalent to two hours of running daily, six days weekly, for 20 years) that do not apply to average or even serious recreational athletes.
Scandinavian cohort studies and research examining 80- and 90-year-old cross-country skiers who began competing in the 1930s-1950s demonstrate that despite imaging abnormalities potentially indicating fibrosis, these athletes maintained average VO2 max values near 40 ml/kg/min and remained independent into their late 80s and 90s. Runners completing 40 miles weekly show up to 25% lower coronary heart disease risk compared to those running 13 miles weekly.
Multiple studies involving hundreds of thousands of participants indicate no upper limit for VO2 max benefits. Higher VO2 max consistently correlates with higher survival rates without evidence of inverted U-shaped relationships where excessive fitness creates increased risk. Cleveland Clinic research following over 125,000 people for 15-20 years found the greatest mortality risk among the least fit individuals, while those in the 98th percentile of fitness showed approximately 20% mortality risk reduction.
A study of 2,000 men and women with an average age in the early 50s who exercised 35 hours weekly for an average of 28 years provides compelling data. Among the 66 individuals meeting this extreme exercise criteria, only two deaths occurred over 10-year follow-up, and neither resulted from cardiovascular disease. This represents some of the most extreme exercise patterns studied, with no observed cardiovascular mortality.
"This entire topic is intellectually interesting. It is clinically worth knowing, but it is not worth worrying about."
— Dr. Paul Thompson
Keep Andy Galpin in your library
Save the videos and channels worth coming back to, and find them again in one place.
